DegenRx Overview
- Year Founded
-
2018
- Status
-
Out of Business
- Employees
-
2
- Latest Deal Type
-
Out of Business
DegenRx General Information
Description
Operator of a gene therapy company intended to find and develop treatments for neurodegenerative diseases. The company uses adeno-associated viral vectors to deliver genes into the brain, where they can initiate the local production of therapeutic antibodies for the treatment of central nervous system diseases such as Alzheimer's and Parkinson's disease, enabling patients to have effective treatment options for diseases such as Alzheimer's and Parkinson's.
Contact Information
Website
www.degenrx.comCorporate Office
- Maidstone 48A
- 5026 SK Tilburg
- Netherlands
Corporate Office
- Maidstone 48A
- 5026 SK Tilburg
- Netherlands
DegenRx Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 2. Out of Business | 15-Aug-2026 | Completed | Out of Business | |||
| 1. Early Stage VC (Series A) | 20-Dec-2018 | Completed | Pre-Clinical Trials |
DegenRx Patents
DegenRx Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| JP-2023024448-A | A novel amyloid-beta oligomer-specific binding molecule | Pending | 07-Nov-2016 | ||
| AU-2017354743-A1 | Novel amyloid beta oligomer specific binding molecule | Inactive | 07-Nov-2016 | ||
| CA-3042853-A1 | Novel amyloid beta oligomer specific binding molecule | Pending | 07-Nov-2016 | ||
| EP-3535293-A1 | Novel amyloid beta oligomer specific binding molecule | Inactive | 07-Nov-2016 | C07K16/18 |
DegenRx Signals
DegenRx FAQs
-
When was DegenRx founded?
DegenRx was founded in 2018.
-
Where is DegenRx headquartered?
DegenRx is headquartered in Tilburg, Netherlands.
-
What is the size of DegenRx?
DegenRx has 2 total employees.
-
What industry is DegenRx in?
DegenRx’s primary industry is Biotechnology.
-
Is DegenRx a private or public company?
DegenRx is a Private company.
-
What is DegenRx’s current revenue?
The current revenue for DegenRx is .
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process